Cantor Fitzgerald analyst Sarah James initiated coverage of NextGen Healthcare with an Overweight rating and $21 price target. NextGen provides one of the largest interoperability health data platforms, MirthConnect, used in one third of all U.S. health information exchanges and 39 countries, the analyst tells investors in a research note. The firm sees the company’s suite of offerings as well positioned for the shift of U.S. healthcare into value-based care and shared savings. The network effect of NextGen’s “broad” installed base for MirthConnect is a driver for the company to outpace market growth in value-based care technology support tools, Cantor contends.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NXGN:
- NextGen Healthcare initiated with an Overweight at Cantor Fitzgerald
- NextGen Healthcare, Luma Health enter expanded strategic alliance
- NextGen Healthcare up 8% after Reuters says company exploring possible sale
- NextGen Healthcare exploring sale with help of Morgan Stanley, Reuters says
- NextGen Healthcare exploring possible sale, Reuters reports